Recent news releases
-
Mar 31, 2021 Apotex Corp. Issues Voluntary Nationwide Recall of Guanfacine Extended-Release Tablets 2mg due to trace amounts of Quetiapine Fumarate
-
Dec 2, 2020 Apotex Corp. names new President & Chief Executive Officer
-
Jun 5, 2020 Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
-
May 27, 2020 Apotex Corp. Issues Voluntary Nationwide Recall of Metformin Hydrochloride Extended-Release Tablets 500mg Due to the Detection of N-nitrosodimethylamine (NDMA)
-
May 7, 2020 Apotex Corp. Resolves US Federal Government Antitrust Investigation Regarding Generic Drug Pricing
-
Sep 25, 2019 Apotex Corp. Issues Voluntary Nationwide Recall of Ranitidine Tablets 75mg and 150mg (All pack sizes and Formats) due to the potential for Detection of an Amount of Unexpected Impurity,N-nitrosodimethylamine (NDMA) Impurity in the product